- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about GSK
Recent news which mentions GSK
FDA Approves GSK's Whooping Cough Vaccine During Pregnancy For Prevention In Infants
October 10, 2022
Tickers
GSK
From Benzinga
Want $1,000 in Passive Income? Don't Make These 3 Mistakes
October 07, 2022
From Motley Fool
From MarketWatch
From Motley Fool
AnaptysBio / GSK-Partnered Immuno-Oncology Agent Meets Primary Goal In Lung Cancer Trial
October 05, 2022
From Benzinga
DEA-Licensed Pharmaceutical Cannabis Research Company Announces $20M Series A Funding Round
October 04, 2022
From Benzinga
This Is the Best Time to Buy These 7 Long-Term Dividend Stocks
October 03, 2022
From InvestorPlace
From Benzinga
7 Consumer Stocks to Sell Before They Die
September 28, 2022
From InvestorPlace
2 High Yielders Decimated By The Russia-Ukraine War: Is Now The Time To Buy?
September 27, 2022
From Benzinga
iPhone 14 Popular In China?, Netflix May Lose Comics, Elon Musk's Starlink Slows, Byron Allen Faces $10B Lawsuit And More Top Financial Media Stories Monday, Sept. 26
September 26, 2022
From Benzinga
Burberry Finance Chief Joins GSK As First Woman CFO
September 26, 2022
From Benzinga
Unilever CEO Alan Jope To Retire Next Year
September 26, 2022
From Benzinga
7 Stocks to Buy That Can Soar in Good Times or in Bad
September 22, 2022
From InvestorPlace
Spero Therapeutics (SPRO) Soars 137% on Exclusive License Agreement
September 22, 2022
From InvestorPlace
From Benzinga
From InvestorPlace
From Benzinga
Jim Cramer Says This Stock Is A 'Great Spec And I Usually Don't Say That,' And Analysts Approve
September 21, 2022
From Benzinga
3 Biotech Stocks to Buy Now for Extraordinary Gains
September 20, 2022
From InvestorPlace
2 Dividend Stocks to Double Up On Right Now
September 20, 2022
From Motley Fool
Haleon Clocks Double Digit Growth In Interim Revenue, Profits; Sticks To Annual Guidance
September 20, 2022
From Benzinga
Haleon Shares Pop After Rejecting Zantac Indemnification Requests From GSK, Pfizer
September 20, 2022
From Benzinga
Theravance Outlines $250M Capital Return Program; To Repurchase GSK's Entire Holdings
September 19, 2022
From Benzinga
From Benzinga
Pfizer's Pentavalent Meningococcal Vaccine Candidate Shows Efficacy In Adolescents
September 15, 2022
From Benzinga
AnaptysBio Sells Royalty Interest In Cancer Drug For $45M
September 12, 2022
From Benzinga
SpringWorks Shares Pop After Expanded Multiple Myeloma Pact With GSK
September 07, 2022
From Benzinga
Sanofi-GSK COVID-19 Vaccine May See European Approval Soon: Report
September 06, 2022
From Benzinga
2 Top Trends to Invest $2,000 in Ahead of the Crowd
September 05, 2022
From Motley Fool
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.